Q2 2021 Holdings
Filed 2021-08-13 | 19 holdings | $65.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $21.1M | 312,598 | 32.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $20.8M | 69,144 | 32.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.6M | 1,558,975 | 19.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $10.3M | 423,817 | 15.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $36.5K | 1,283,887 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $34.0K | 1,970,259 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $13.2K | 505,890 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $13.0K | 673,905 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $13.0K | 152,162 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $11.1K | 2,533,237 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $8.9K | 864,214 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $8.7K | 896,281 | 0.0% |
| Catabasis Pharmaceuticals in(CATBEUR) | COM NEW | 14875P206 | $8.6K | 4,092,166 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $8.6K | 888,980 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $7.8K | 178,058 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $7.4K | 210,000 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $6.3K | 149,333 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $642 | 35,092 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $549 | 83,944 | 0.0% |